ESR1 and breast cancer: Previous studies have shown that chromatin interactions in breast cancer cells differ from normal mammary epithelial cells (Barutcu et al., 2015) and estrogen-receptor binding is involved in three-dimensional (3D) genome reorganization in endocrine-resistant breast cancer (Zhou et al., 2019; Achinger-Kawecka et al., 2020).